Predictive Oncology Inc. Quarterly Amortization of Intangible Assets in USD from Q2 2013 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Predictive Oncology Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q2 2013 to Q4 2024.
  • Predictive Oncology Inc. Amortization of Intangible Assets for the quarter ending December 31, 2024 was $6.14K, unchanged year-over-year.
  • Predictive Oncology Inc. Amortization of Intangible Assets for the twelve months ending December 31, 2024 was $26.5K, a 0.09% increase year-over-year.
  • Predictive Oncology Inc. annual Amortization of Intangible Assets for 2024 was $26.5K, a 0.09% increase from 2023.
  • Predictive Oncology Inc. annual Amortization of Intangible Assets for 2023 was $26.5K, a 93.6% decline from 2022.
  • Predictive Oncology Inc. annual Amortization of Intangible Assets for 2022 was $415K, a 10.8% increase from 2021.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $6.14K $0 0% Dec 31, 2024 10-K 2025-03-31
Q3 2024 $6.62K -$1 -0.02% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $6.86K -$172 -2.45% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $6.86K +$198 +2.97% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $6.14K -$97.9K -94.1% Dec 31, 2023 10-K 2025-03-31
Q3 2023 $6.62K -$97.2K -93.6% Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $7.04K -$96.3K -93.2% Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $6.67K -$96.9K -93.6% Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $104K -$20.6K -16.5% Dec 31, 2022 10-K 2024-03-28
Q3 2022 $104K +$20.2K +24.1% Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $103K +$20.3K +24.4% Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $104K +$20.5K +24.7% Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $125K +$41.8K +50.5% Dec 31, 2021 10-K 2023-03-21
Q3 2021 $83.6K +$6.36K +8.23% Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $83.1K +$5.9K +7.65% Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $83K +$6.54K +8.55% Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $82.8K -$8.31K -9.12% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $77.3K -$16.2K -17.3% Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $77.2K -$11.2K -12.7% Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $76.5K +$58.9K +334% Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $91.1K +$74.6K +452% Dec 31, 2019 10-K 2021-03-15
Q3 2019 $93.4K +$55K +143% Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $88.4K +$84.3K +2072% Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $17.6K +$14K +381% Mar 31, 2019 10-Q 2020-06-08
Q4 2018 $16.5K +$12.9K +356% Dec 31, 2018 10-K 2020-04-01
Q3 2018 $38.4K +$35.1K +1072% Sep 30, 2018 10-Q 2019-11-15
Q2 2018 $4.07K +$1.17K +40.2% Jun 30, 2018 10-Q 2019-08-19
Q1 2018 $3.67K +$783 +27.1% Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $3.62K +$741 +25.7% Dec 31, 2017 10-K/A 2019-04-02
Q3 2017 $3.28K +$761 +30.3% Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $2.9K +$1.02K +54.5% Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $2.89K +$1.06K +57.6% Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $2.88K +$1.11K +62.7% Dec 31, 2016 10-K 2018-04-02
Q3 2016 $2.52K +$883 +54.1% Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $1.88K +$434 +30.1% Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $1.83K +$388 +26.9% Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $1.77K Dec 31, 2015 10-K 2017-03-15
Q3 2015 $1.63K +$1.63K Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $1.44K +$1.44K Jun 30, 2015 10-Q 2016-08-12
Q1 2015 $1.44K +$1.44K Mar 31, 2015 10-Q 2016-05-23
Q3 2014 $0 Sep 30, 2014 10-Q 2015-12-09
Q2 2014 $0 -$141K -100% Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $0 Mar 31, 2014 10-Q 2015-05-18
Q2 2013 $141K Jun 30, 2013 10-K 2015-04-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.